Digital From 0.1% to infinity: How increasingly larger GPT models ar... Using GPT can drastically increase the probability of success in the process of finding new molecules that can be used for drugs.
News UK trumpets £1bn investment plan from BioNTech BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.
News Imec showcases ingestible sensor for gut studies Imec will demonstrate an ingestible sensor device today that can monitor gut health and could be a valuable tool for research and clinical trials.
News Lilly forges a $415m ALS alliance with UK biotech Alchemab Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients.
News AstraZeneca joins Tempus, Pathos in cancer AI project AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology.
News Alphabet's Isomorphic raises $600m for AI drug discovery Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine and advance its pipeline.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face